Shares of BioMS Medical Corp (MS.TO: Quote) plunged 90 percent on Tuesday after the company and Eli Lilly and Co (LLY.N: Quote) said their multiple sclerosis treatment failed to delay the progression of the disease in a late-stage trial.
Here is a table of clinical trials of Rebif.
the first patients have been enrolled in MAESTRO-03, its U.S. pivotal phase III clinical trial of MBP8298, a proprietary synthetic peptide for the treatment of multiple sclerosis
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), is pleased to announce Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company’s pivotal phase III clinical trial of its lead dru
BioMS Medical Corp (TSX: MS), a leading developer of products for the treatment of multiple sclerosis (MS), today announced that it has initiated MAESTRO-02, the open-label follow-on portion to its MAESTRO-01 pivotal phase II/III clinical trial of MBP8298
"All things considered, if I had to choose among a stroke, a brain tumor, or multiple sclerosis, I'd pick multiple sclerosis,'' Maxwell says.
A double-blind, placebo controlled multicentre study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis
More than 300 patients enrolled in pivotal phase II/III multiple sclerosis trial
ABT-874 is a human anti-IL-12 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases.
In one small trial of 27 people with Secondary Progressive MS (SPMS), the drug was found to virtually eliminate the formation of new lesions and the inflammation associated with the disease for at least eighteen months.
Novantrone belongs to the general group of medicines called antineoplastics. Prior to its approval for use in MS, it was used only to treat certain forms of cancer. It acts in MS by suppressing the activity of T cells, B cells, and macrophages that are th
by Trevis Gleason. A personal take on multiple sclerosis
Physical activity is extremely important for individuals with MS, and yoga is now recognized as an excellent means of MS management, whether the individual manifests little or no outward signs of the disease, or whether they spend most of their time in a
The Edward Bronfman Family Foundation Research Clinic in Secondary Progressive Multiple Sclerosis is dedicated to researching alternative forms of therapy to alleviate the pain associated with Secondary Progressive Multiple Sclerosis (SPMS) and is associa
EAE (experimental allergic encephalomyelitis) is the standard benchmark animal methodology for the study of MS. ReceptoPharm's drug, RPI-78M, proved to be very effective in preventing the onset of disability in acute and chronic models of the disease
